응고 검사 시장 : 제품별, 용도별, 최종 사용자별 - 세계 기회 분석 및 산업 예측(2021-2031년)

The global coagulation testing market size is envisioned to garner $8,777.3 million by 2031, growing from $3,101.7 million in 2021 at a CAGR of 11.5% from 2022 to 2031.

Medical professionals use coagulation tests to evaluate the hemostasis system. A coagulometer, which monitors and assesses the rate of clot formation or blood coagulation, is mostly used to conduct this test. These examinations reduce the risk of heart attack, thrombosis, and embolism by detecting the presence of blood clots in blood arteries.

Hemostasis (coagulation), a complicated process that regulates blood flow and clot formation, is controlled by numerous enzymes and proteins.

The market is expanding as a result of ongoing technological developments in coagulation testing equipment. The key growth reasons for the coagulation testing market are the rising prevalence of different blood clotting disorders, including deep vein thrombosis (DVT) and haemophilia, as well as the global ageing population. The market is comprehensively evaluated in the study on the global coagulation testing market growth.

Due to stringent government regulations along with high risk and costs associated with tests and treatment which limits its usage to only the population which is economically capable gives a negative impact on the global coagulation testing markets.

In the self-testing technology, the smartphone-based blood coagulation testing device which is driving the growth of the market helps to monitors the blood flow in patients by undergoing an anticoagulant therapy. These factors drives the coagulation testing market demand.

The COVID-19 pandemic brought about a number of difficulties that resulted in significant economic losses as a result of the global shutdown of many firms. There were established import-export limitations. The COVID-19 pandemic has had a beneficial impact on the market for coagulation testing worldwide. Numerous government agencies are taking a number of actions to help businesses survive the coronavirus epidemic. Many government agencies are taking a number of actions to help businesses survive the coronavirus outbreak.

The key players profiled in this report include Thermo Fisher Scientific Inc., Helena Laboratories Corporation., Micropoint Biosciences, Medtronic, F. Hoffmann-La Roche Ltd, NIHON KOHDEN CORPORATION., Abbott., Sysmex Corporation, BD Biosciences., and Danaher.

Key Benefits For Stakeholders

• This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the coagulation testing market analysis from 2021 to 2031 to identify the prevailing coagulation testing market opportunities.
• The market research is offered along with information related to key drivers, restraints, and opportunities.
• Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
• In-depth analysis of the coagulation testing market segmentation assists to determine the prevailing market opportunities.
• Major countries in each region are mapped according to their revenue contribution to the global market.
• Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
• The report includes the analysis of the regional as well as global coagulation testing market trends, key players, market segments, application areas, and market growth strategies.

Key Market Segments

By Product

• Instruments
• Consumables

By Application

• Prothrombin Time
• Activated Partial Thromboplastin Time
• Thrombin Time
• Activated Clotting Time

By End User

• Hospitals
• Clinical Laboratories
• Point-of-Care Testing
• Others

By Region

• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Spain
  • Italy
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Rest Of Asia Pacific
• LAMEA
  • Brazil
  • Saudi Arabia
  • UAE
  • South Africa
  • Rest of LAMEA
• Key Market Players
  • Alere Inc.
  • Nihon Kohden Corporation
  • F. Hoffmann-La Roche Ltd.
  • Sysmex Corporation
  • Thermo Fisher Scientific Inc.
  • Diagnostica Stago Sas
  • Helena Laboratories
  • Abbott Laboratories
  • Medtronic plc
  • Micropoint Biosciences

TABLE OF CONTENTS

CHAPTER 1:INTRODUCTION

• 1.1.Report description
• 1.2.Key market segments
• 1.3.Key benefits to the stakeholders
• 1.4.Research Methodology
  • 1.4.1.Secondary research
  • 1.4.2.Primary research
  • 1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

• 2.1.Key findings of the study
• 2.2.CXO Perspective

CHAPTER 3:MARKET OVERVIEW

• 3.1.Market definition and scope
• 3.2.Key findings
  • 3.2.1.Top investment pockets
• 3.3.Porter's five forces analysis
• 3.4.Top player positioning
• 3.5.Market dynamics
  • 3.5.1.Drivers
  • 3.5.2.Restraints
  • 3.5.3.Opportunities
• 3.6.COVID-19 Impact Analysis on the market
• 3.7.Value Chain Analysis
• 3.8.Market Share Analysis
• 3.9.Regulatory Guidelines
• 3.10.Key Regulation Analysis
• 3.11.Patent Landscape

CHAPTER 4: COAGULATION TESTING MARKET, BY PRODUCT

• 4.1 Overview
  • 4.1.1 Market size and forecast
• 4.2 Instruments
  • 4.2.1 Key market trends, growth factors and opportunities
  • 4.2.2 Market size and forecast, by region
  • 4.2.3 Market analysis by country
• 4.3 Consumables
  • 4.3.1 Key market trends, growth factors and opportunities
  • 4.3.2 Market size and forecast, by region
  • 4.3.3 Market analysis by country

CHAPTER 5: COAGULATION TESTING MARKET, BY APPLICATION

• 5.1 Overview
  • 5.1.1 Market size and forecast
• 5.2 Prothrombin Time
  • 5.2.1 Key market trends, growth factors and opportunities
  • 5.2.2 Market size and forecast, by region
  • 5.2.3 Market analysis by country
• 5.3 Activated Partial Thromboplastin Time
  • 5.3.1 Key market trends, growth factors and opportunities
  • 5.3.2 Market size and forecast, by region
  • 5.3.3 Market analysis by country
• 5.4 Thrombin Time
  • 5.4.1 Key market trends, growth factors and opportunities
  • 5.4.2 Market size and forecast, by region
  • 5.4.3 Market analysis by country
• 5.5 Activated Clotting Time
  • 5.5.1 Key market trends, growth factors and opportunities
  • 5.5.2 Market size and forecast, by region
  • 5.5.3 Market analysis by country

CHAPTER 6: COAGULATION TESTING MARKET, BY END USER

• 6.1 Overview
  • 6.1.1 Market size and forecast
• 6.2 Hospitals
  • 6.2.1 Key market trends, growth factors and opportunities
  • 6.2.2 Market size and forecast, by region
  • 6.2.3 Market analysis by country
• 6.3 Clinical Laboratories
  • 6.3.1 Key market trends, growth factors and opportunities
  • 6.3.2 Market size and forecast, by region
  • 6.3.3 Market analysis by country
• 6.4 Point-of-Care Testing
  • 6.4.1 Key market trends, growth factors and opportunities
  • 6.4.2 Market size and forecast, by region
  • 6.4.3 Market analysis by country
• 6.5 Others
  • 6.5.1 Key market trends, growth factors and opportunities
  • 6.5.2 Market size and forecast, by region
  • 6.5.3 Market analysis by country

CHAPTER 7: COAGULATION TESTING MARKET, BY REGION

• 7.1 Overview
  • 7.1.1 Market size and forecast
• 7.2 North America
  • 7.2.1 Key trends and opportunities
  • 7.2.2 North America Market size and forecast, by Product
  • 7.2.3 North America Market size and forecast, by Application
  • 7.2.4 North America Market size and forecast, by End User
  • 7.2.5 North America Market size and forecast, by country
    • 7.2.5.1 U.S.
    • 7.2.5.1.1 Market size and forecast, by Product
    • 7.2.5.1.2 Market size and forecast, by Application
    • 7.2.5.1.3 Market size and forecast, by End User
    • 7.2.5.2 Canada
    • 7.2.5.2.1 Market size and forecast, by Product
    • 7.2.5.2.2 Market size and forecast, by Application
    • 7.2.5.2.3 Market size and forecast, by End User
    • 7.2.5.3 Mexico
    • 7.2.5.3.1 Market size and forecast, by Product
    • 7.2.5.3.2 Market size and forecast, by Application
    • 7.2.5.3.3 Market size and forecast, by End User
• 7.3 Europe
  • 7.3.1 Key trends and opportunities
  • 7.3.2 Europe Market size and forecast, by Product
  • 7.3.3 Europe Market size and forecast, by Application
  • 7.3.4 Europe Market size and forecast, by End User
  • 7.3.5 Europe Market size and forecast, by country
    • 7.3.5.1 Germany
    • 7.3.5.1.1 Market size and forecast, by Product
    • 7.3.5.1.2 Market size and forecast, by Application
    • 7.3.5.1.3 Market size and forecast, by End User
    • 7.3.5.2 United Kingdom
    • 7.3.5.2.1 Market size and forecast, by Product
    • 7.3.5.2.2 Market size and forecast, by Application
    • 7.3.5.2.3 Market size and forecast, by End User
    • 7.3.5.3 France
    • 7.3.5.3.1 Market size and forecast, by Product
    • 7.3.5.3.2 Market size and forecast, by Application
    • 7.3.5.3.3 Market size and forecast, by End User
    • 7.3.5.4 Spain
    • 7.3.5.4.1 Market size and forecast, by Product
    • 7.3.5.4.2 Market size and forecast, by Application
    • 7.3.5.4.3 Market size and forecast, by End User
    • 7.3.5.5 Italy
    • 7.3.5.5.1 Market size and forecast, by Product
    • 7.3.5.5.2 Market size and forecast, by Application
    • 7.3.5.5.3 Market size and forecast, by End User
    • 7.3.5.6 Rest of Europe
    • 7.3.5.6.1 Market size and forecast, by Product
    • 7.3.5.6.2 Market size and forecast, by Application
    • 7.3.5.6.3 Market size and forecast, by End User
• 7.4 Asia-Pacific
  • 7.4.1 Key trends and opportunities
  • 7.4.2 Asia-Pacific Market size and forecast, by Product
  • 7.4.3 Asia-Pacific Market size and forecast, by Application
  • 7.4.4 Asia-Pacific Market size and forecast, by End User
  • 7.4.5 Asia-Pacific Market size and forecast, by country
    • 7.4.5.1 China
    • 7.4.5.1.1 Market size and forecast, by Product
    • 7.4.5.1.2 Market size and forecast, by Application
    • 7.4.5.1.3 Market size and forecast, by End User
    • 7.4.5.2 Japan
    • 7.4.5.2.1 Market size and forecast, by Product
    • 7.4.5.2.2 Market size and forecast, by Application
    • 7.4.5.2.3 Market size and forecast, by End User
    • 7.4.5.3 India
    • 7.4.5.3.1 Market size and forecast, by Product
    • 7.4.5.3.2 Market size and forecast, by Application
    • 7.4.5.3.3 Market size and forecast, by End User
    • 7.4.5.4 South Korea
    • 7.4.5.4.1 Market size and forecast, by Product
    • 7.4.5.4.2 Market size and forecast, by Application
    • 7.4.5.4.3 Market size and forecast, by End User
    • 7.4.5.5 Australia
    • 7.4.5.5.1 Market size and forecast, by Product
    • 7.4.5.5.2 Market size and forecast, by Application
    • 7.4.5.5.3 Market size and forecast, by End User
    • 7.4.5.6 Rest Of Asia Pacific
    • 7.4.5.6.1 Market size and forecast, by Product
    • 7.4.5.6.2 Market size and forecast, by Application
    • 7.4.5.6.3 Market size and forecast, by End User
• 7.5 LAMEA
  • 7.5.1 Key trends and opportunities
  • 7.5.2 LAMEA Market size and forecast, by Product
  • 7.5.3 LAMEA Market size and forecast, by Application
  • 7.5.4 LAMEA Market size and forecast, by End User
  • 7.5.5 LAMEA Market size and forecast, by country
    • 7.5.5.1 Brazil
    • 7.5.5.1.1 Market size and forecast, by Product
    • 7.5.5.1.2 Market size and forecast, by Application
    • 7.5.5.1.3 Market size and forecast, by End User
    • 7.5.5.2 Saudi Arabia
    • 7.5.5.2.1 Market size and forecast, by Product
    • 7.5.5.2.2 Market size and forecast, by Application
    • 7.5.5.2.3 Market size and forecast, by End User
    • 7.5.5.3 UAE
    • 7.5.5.3.1 Market size and forecast, by Product
    • 7.5.5.3.2 Market size and forecast, by Application
    • 7.5.5.3.3 Market size and forecast, by End User
    • 7.5.5.4 South Africa
    • 7.5.5.4.1 Market size and forecast, by Product
    • 7.5.5.4.2 Market size and forecast, by Application
    • 7.5.5.4.3 Market size and forecast, by End User
    • 7.5.5.5 Rest of LAMEA
    • 7.5.5.5.1 Market size and forecast, by Product
    • 7.5.5.5.2 Market size and forecast, by Application
    • 7.5.5.5.3 Market size and forecast, by End User

CHAPTER 8: COMPANY LANDSCAPE

• 8.1. Introduction
• 8.2. Top winning strategies
• 8.3. Product Mapping of Top 10 Player
• 8.4. Competitive Dashboard
• 8.5. Competitive Heatmap
• 8.6. Key developments

CHAPTER 9: COMPANY PROFILES

• 9.1 Alere Inc.
  • 9.1.1 Company overview
  • 9.1.2 Company snapshot
  • 9.1.3 Operating business segments
  • 9.1.4 Product portfolio
  • 9.1.5 Business performance
  • 9.1.6 Key strategic moves and developments
• 9.2 Nihon Kohden Corporation
  • 9.2.1 Company overview
  • 9.2.2 Company snapshot
  • 9.2.3 Operating business segments
  • 9.2.4 Product portfolio
  • 9.2.5 Business performance
  • 9.2.6 Key strategic moves and developments
• 9.3 F. Hoffmann-La Roche Ltd.
  • 9.3.1 Company overview
  • 9.3.2 Company snapshot
  • 9.3.3 Operating business segments
  • 9.3.4 Product portfolio
  • 9.3.5 Business performance
  • 9.3.6 Key strategic moves and developments
• 9.4 Sysmex Corporation
  • 9.4.1 Company overview
  • 9.4.2 Company snapshot
  • 9.4.3 Operating business segments
  • 9.4.4 Product portfolio
  • 9.4.5 Business performance
  • 9.4.6 Key strategic moves and developments
• 9.5 Thermo Fisher Scientific Inc.
  • 9.5.1 Company overview
  • 9.5.2 Company snapshot
  • 9.5.3 Operating business segments
  • 9.5.4 Product portfolio
  • 9.5.5 Business performance
  • 9.5.6 Key strategic moves and developments
• 9.6 Diagnostica Stago Sas
  • 9.6.1 Company overview
  • 9.6.2 Company snapshot
  • 9.6.3 Operating business segments
  • 9.6.4 Product portfolio
  • 9.6.5 Business performance
  • 9.6.6 Key strategic moves and developments
• 9.7 Helena Laboratories
  • 9.7.1 Company overview
  • 9.7.2 Company snapshot
  • 9.7.3 Operating business segments
  • 9.7.4 Product portfolio
  • 9.7.5 Business performance
  • 9.7.6 Key strategic moves and developments
• 9.8 Abbott Laboratories
  • 9.8.1 Company overview
  • 9.8.2 Company snapshot
  • 9.8.3 Operating business segments
  • 9.8.4 Product portfolio
  • 9.8.5 Business performance
  • 9.8.6 Key strategic moves and developments
• 9.9 Medtronic plc
  • 9.9.1 Company overview
  • 9.9.2 Company snapshot
  • 9.9.3 Operating business segments
  • 9.9.4 Product portfolio
  • 9.9.5 Business performance
  • 9.9.6 Key strategic moves and developments
• 9.10 Micropoint Biosciences
  • 9.10.1 Company overview
  • 9.10.2 Company snapshot
  • 9.10.3 Operating business segments
  • 9.10.4 Product portfolio
  • 9.10.5 Business performance
  • 9.10.6 Key strategic moves and developments